This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
submitted work | 410 |
coronavirus disease | 405 |
acute respiratory | 347 |
financial relationships | 276 |
novel coronavirus | 271 |
respiratory syndrome | 241 |
severe acute | 224 |
syndrome coronavirus | 168 |
respiratory distress | 153 |
cord uid | 146 |
doc id | 146 |
cureus doi | 146 |
three years | 141 |
payment services | 140 |
services info | 140 |
icmje uniform | 139 |
authors declare | 139 |
uniform disclosure | 139 |
disclosure form | 139 |
previous three | 138 |
financial support | 137 |
mental health | 126 |
risk factors | 125 |
united states | 117 |
human subjects | 117 |
mechanical ventilation | 114 |
distress syndrome | 111 |
medical students | 104 |
mg dl | 103 |
health care | 98 |
clinical characteristics | 97 |
intensive care | 94 |
cloth masks | 92 |
myocardial injury | 90 |
chain reaction | 90 |
polymerase chain | 89 |
case series | 89 |
world health | 88 |
health organization | 84 |
case report | 83 |
cardiac injury | 83 |
animal subjects | 82 |
respiratory failure | 80 |
respiratory symptoms | 79 |
public health | 77 |
clinical features | 77 |
medical history | 76 |
severe covid | 74 |
diabetes mellitus | 73 |
systematic review | 73 |
chest ct | 69 |
hospitalized patients | 69 |
care unit | 68 |
critically ill | 67 |
blood pressure | 67 |
ng ml | 63 |
protective equipment | 63 |
mortality rate | 61 |
emergency department | 60 |
ct scan | 59 |
healthcare professionals | 58 |
social distancing | 57 |
old male | 55 |
oxygen saturation | 55 |
personal protective | 53 |
cancer patients | 53 |
reactive protein | 53 |
general public | 52 |
ischemic stroke | 52 |
clinical trials | 50 |
tested positive | 50 |
myocardial infarction | 49 |
pulmonary embolism | 49 |
clinical presentation | 49 |
infected patients | 48 |
cohort study | 47 |
per minute | 47 |
past medical | 46 |
patients infected | 46 |
ill patients | 46 |
sample size | 45 |
converting enzyme | 45 |
normal range | 45 |
blood cultures | 45 |
three days | 44 |
middle east | 44 |
computed tomography | 44 |
social media | 44 |
neurological manifestations | 44 |
severe disease | 44 |
case reports | 44 |
respiratory rate | 43 |
physical examination | 43 |
positive patients | 43 |
cytokine storm | 42 |
coronary artery | 42 |
heart rate | 42 |
glass opacities | 42 |
nervous system | 41 |
involve animal | 41 |
statistically significant | 41 |
surgical masks | 40 |
first case | 40 |
dry cough | 40 |
chronic disease | 40 |
respiratory tract | 39 |
white blood | 39 |
patient care | 39 |
increased risk | 39 |
two days | 39 |
confirmed cases | 39 |
healthcare workers | 38 |
high risk | 38 |
face mask | 38 |
mental status | 38 |
organ failure | 38 |
disease control | 37 |
cardiovascular disease | 37 |
room air | 36 |
chest pain | 36 |
retrospective study | 36 |
confirmed covid | 36 |
infectious disease | 36 |
acute kidney | 36 |
sore throat | 35 |
significant difference | 35 |
heart failure | 35 |
blood cell | 35 |
viral load | 34 |
nasal cannula | 34 |
diabetic ketoacidosis | 34 |
one patient | 34 |
pg ml | 34 |
ventricular septal | 33 |
medical education | 33 |
clinical course | 33 |
east respiratory | 33 |
incubation period | 33 |
face masks | 33 |
coronavirus pneumonia | 33 |
higher risk | 32 |
vital signs | 31 |
neurosurgical education | 31 |
immune system | 31 |
hospital stay | 31 |
old female | 31 |
another study | 31 |
five days | 31 |
kidney injury | 31 |
two weeks | 31 |
patients presenting | 31 |
among patients | 30 |
viral infection | 30 |
final year | 30 |
infectious diseases | 30 |
health disparities | 30 |
immune response | 30 |
acute myocardial | 30 |
review board | 30 |
ct findings | 29 |
transplant recipients | 29 |
epub ahead | 29 |
hospital day | 29 |
healthcare system | 29 |
year students | 29 |
viral infections | 29 |
awake proning | 29 |
reverse transcription | 29 |
critical care | 29 |
type ii | 29 |
general population | 28 |
staphylococcus aureus | 28 |
neurological symptoms | 28 |
extubation stridor | 28 |
laboratory findings | 28 |
coronavirus infection | 28 |
img applicants | 28 |
radiation therapy | 28 |
acute appendicitis | 27 |
cardiogenic shock | 27 |
global pandemic | 27 |
drug use | 27 |
membrane oxygenation | 27 |
artery disease | 27 |
disease severity | 27 |
four days | 26 |
severe respiratory | 26 |
mean age | 26 |
clinical trial | 26 |
severe cases | 26 |
days later | 26 |
showed bilateral | 26 |
issued approval | 26 |
extracorporeal membrane | 26 |
fatality rate | 26 |
hospital course | 26 |
new york | 26 |
mortality rates | 26 |
infected pneumonia | 26 |
twice daily | 26 |
seven days | 26 |
nasopharyngeal swab | 26 |
prone positioning | 25 |
holy communion | 25 |
central nervous | 25 |
total number | 25 |
rhode island | 25 |
abdominal pain | 25 |
migrant children | 25 |
respiratory status | 24 |
opioid use | 24 |
oral presentation | 24 |
pulmonary disease | 24 |
one day | 24 |
left ventricular | 24 |
iv us | 24 |
emergency room | 24 |
randomized clinical | 23 |
lung cancer | 23 |
type diabetes | 23 |
differential diagnosis | 23 |
institutional review | 23 |
boot camp | 23 |
lung injury | 23 |
bilateral ground | 23 |
patient developed | 23 |
convalescent plasma | 22 |
emergency medicine | 22 |
pcr testing | 22 |
ejection fraction | 22 |
adverse effects | 22 |
adhd patients | 22 |
acute ischemic | 22 |
clinical manifestations | 22 |
pcr test | 22 |
patients hospitalized | 22 |
epithelial cells | 22 |
patient population | 22 |
heart disease | 22 |
virtual conversation | 21 |
retrospective cohort | 21 |
chronic obstructive | 21 |
median age | 21 |
mild symptoms | 21 |
side effects | 21 |
saudi arabia | 21 |
atrial fibrillation | 21 |
primary care | 21 |
inflammatory markers | 21 |
gastrointestinal symptoms | 21 |
even though | 21 |
kidney disease | 21 |
mg twice | 21 |
hypercoagulable state | 21 |
viral rna | 21 |
cardiac arrest | 21 |
lopinavir ritonavir | 21 |
magnetic resonance | 20 |
multiple organ | 20 |
serum ferritin | 20 |
lactate dehydrogenase | 20 |
conversation series | 20 |
overall survival | 20 |
statistical analysis | 20 |
crazy paving | 20 |
higher mortality | 20 |
randomized controlled | 20 |
suspected covid | 20 |
treatment options | 20 |
splenic abscess | 20 |
future studies | 20 |
sars coronavirus | 19 |
examination revealed | 19 |
health literacy | 19 |
elderly patients | 19 |
ray showed | 19 |
ct imaging | 19 |
human participants | 19 |
care providers | 19 |
beats per | 19 |
obstructive pulmonary | 19 |
blood glucose | 19 |
lower lobes | 19 |
respiratory system | 19 |
observational study | 19 |
respiratory droplets | 19 |
pleural effusion | 19 |
clinical suspicion | 19 |
endotracheal intubation | 19 |
significantly higher | 19 |
liver enzymes | 19 |
mg daily | 19 |
viral pneumonia | 19 |
inflammatory response | 19 |
severe ards | 19 |
host cell | 19 |
pregnant women | 18 |
study showed | 18 |
one week | 18 |
test results | 18 |
lung involvement | 18 |
platelet count | 18 |
parathyroid carcinoma | 18 |
study conducted | 18 |
septic shock | 18 |
gy fractions | 18 |
patients may | 18 |
mild disease | 18 |
neurological complications | 18 |
care workers | 18 |
pediatric clerkship | 18 |
septal defect | 17 |
renal failure | 17 |
chronic diseases | 17 |
ffrct analysis | 17 |
descriptive study | 17 |
white matter | 17 |
healthcare providers | 17 |
informed consent | 17 |
multiorgan failure | 17 |
age group | 17 |
deceased patients | 17 |
breaths per | 17 |
blood count | 17 |
use disorder | 17 |
therapeutic anticoagulation | 17 |
may also | 17 |
laboratory tests | 17 |
close contact | 17 |
health information | 17 |
resonance imaging | 17 |
involve human | 17 |
patients admitted | 17 |
data collection | 17 |
human coronavirus | 17 |
blood culture | 17 |
online neurosurgical | 17 |
contact tracing | 17 |
days prior | 17 |
medical school | 17 |
per day | 17 |
patients treated | 17 |
clinical management | 17 |
hyperactivity disorder | 17 |
upper respiratory | 17 |
risk factor | 17 |
pathological findings | 17 |
infection control | 17 |
health outcomes | 17 |
medical masks | 17 |
risk patients | 17 |
imaging features | 16 |
poor prognosis | 16 |
also found | 16 |
sinus bradycardia | 16 |
eye protection | 16 |
patient contact | 16 |
clinical outcomes | 16 |
risk assessment | 16 |
respiratory disease | 16 |
lung disease | 16 |
chronic conditions | 16 |
liver disease | 16 |
altered mental | 16 |
reported cases | 16 |
respiratory infection | 16 |
acute cardiac | 16 |
cell count | 16 |
venous thromboembolism | 16 |
hubei province | 16 |
two patients | 16 |
septal rupture | 16 |
observational studies | 16 |
common symptoms | 16 |
usual care | 16 |
control group | 16 |
hemophagocytic lymphohistiocytosis | 16 |
behavioral health | 16 |
kawasaki disease | 16 |
old man | 16 |
infection may | 16 |
severe pneumonia | 16 |
liver injury | 16 |
likert scale | 16 |
ibm corp | 16 |
patients without | 16 |
chronic kidney | 16 |
came back | 16 |
patient portal | 16 |
also known | 16 |
antibiotic therapy | 16 |
hand hygiene | 16 |
one study | 16 |
health emergency | 16 |
glass opacity | 16 |
four patients | 16 |
patients presented | 16 |
tumor necrosis | 15 |
acute phase | 15 |
asymptomatic infection | 15 |
medical care | 15 |
recent study | 15 |
deficit hyperactivity | 15 |
patient presentation | 15 |
situation report | 15 |
health services | 15 |
qt interval | 15 |
medical schools | 15 |
pulmonary artery | 15 |
overall mortality | 15 |
six days | 15 |
income countries | 15 |
health crisis | 15 |
icu patients | 15 |
cerebral microbleeds | 15 |
standard deviation | 15 |
also reported | 15 |
patients showed | 15 |
invasive mechanical | 15 |
bacterial infection | 15 |
respiratory infections | 15 |
pcr assay | 15 |
high index | 15 |
lymphocyte count | 15 |
organ systems | 15 |
high mortality | 15 |
vein thrombosis | 15 |
virtual case | 15 |
viral replication | 15 |
heated air | 15 |
wide range | 15 |
troponin i | 15 |
three patients | 15 |
clinical practice | 15 |
patients receiving | 15 |
african american | 15 |
complete blood | 15 |
respiratory illness | 15 |
least one | 15 |
medical staff | 15 |
tertiary care | 14 |
care team | 14 |
liver function | 14 |
cardiovascular complications | 14 |
better understand | 14 |
inclusion criteria | 14 |
adult inpatients | 14 |
surgical cases | 14 |
ribonucleic acid | 14 |
commonly used | 14 |
patient presented | 14 |
initial presentation | 14 |
health status | 14 |
surgical face | 14 |
older patients | 14 |
arterial blood | 14 |
acute myocarditis | 14 |
clinical skills | 14 |
lumbar puncture | 14 |
two hours | 14 |
nucleic acid | 14 |
lower lobe | 14 |
pulmonary hypertension | 14 |
recorded oral | 14 |
smokeless tobacco | 14 |
high levels | 14 |
prone position | 14 |
necrosis factor | 14 |
mass gatherings | 14 |
cardiac troponin | 14 |
medical comorbidities | 14 |
sectional study | 14 |
neurologic manifestations | 14 |
medical student | 14 |
serum calcium | 14 |
old woman | 14 |
negative pressure | 14 |
breast cancer | 14 |
mg kg | 14 |
outward protection | 14 |
candida parapsilosis | 14 |
disease course | 14 |
without ppe | 14 |
underlying cvd | 14 |
critical illness | 14 |
neurological examination | 14 |
discharged home | 14 |
cerebrospinal fluid | 14 |
type i | 14 |
coronavirus infections | 14 |
gold standard | 14 |
mass index | 14 |
may cause | 14 |
clinical signs | 14 |
every patient | 14 |
body mass | 14 |
controlled trial | 13 |
young adults | 13 |
segment elevation | 13 |
acquired pneumonia | 13 |
dimer levels | 13 |
medical conditions | 13 |
case highlights | 13 |
clinical studies | 13 |
healthcare systems | 13 |
hospital mortality | 13 |
five patients | 13 |
hong kong | 13 |
thrombotic complications | 13 |
tested negative | 13 |
every day | 13 |
lithium intoxication | 13 |
cancer care | 13 |
ferritin levels | 13 |
treating covid | 13 |
flow nasal | 13 |
control measures | 13 |
inflammatory cytokines | 13 |
spectrum antibiotics | 13 |
significant increase | 13 |
underlying comorbidities | 13 |
many cases | 13 |
hospital admission | 13 |
left lung | 13 |
adverse events | 13 |
within hours | 13 |
hypoxic pulmonary | 13 |
years old | 13 |
hemorrhagic stroke | 13 |
orthopaedic surgery | 13 |
ii diabetes | 13 |
patient remained | 13 |
case fatality | 13 |
median os | 13 |
sudden onset | 13 |
lung fields | 13 |
study clinical | 13 |
different types | 13 |
oxygen supplementation | 13 |
study population | 13 |
within one | 13 |
will help | 13 |
widely used | 13 |
right ventricular | 13 |
patient reported | 13 |
pulmonary vasoconstriction | 13 |
six weeks | 13 |
asymptomatic patients | 13 |
nasal congestion | 13 |
performed using | 12 |
cov infection | 12 |
exclusion criteria | 12 |
hand washing | 12 |
supplemental oxygen | 12 |
two cases | 12 |
invasive ventilation | 12 |
present case | 12 |
reverse transcriptase | 12 |
human coronaviruses | 12 |
ccb group | 12 |
surgical mask | 12 |
case study | 12 |
ace receptor | 12 |
risk score | 12 |
lower respiratory | 12 |
prospective cohort | 12 |
female patient | 12 |
spike protein | 12 |
dl vl | 12 |
increased mortality | 12 |
proinflammatory cytokines | 12 |
male presented | 12 |
healthcare personnel | 12 |
million people | 12 |
treatment strategies | 12 |
increased incidence | 12 |
community transmission | 12 |
several studies | 12 |
preceding quarters | 12 |
medical management | 12 |
acute lung | 12 |
protease inhibitor | 12 |
superimposed bacterial | 12 |
travel history | 12 |
time reverse | 12 |
acute pulmonary | 12 |
elementary schools | 12 |
statistical significance | 12 |
vertical transmission | 12 |
eight days | 12 |
three months | 12 |
united kingdom | 12 |
ace receptors | 12 |
health problems | 12 |
patients suffering | 12 |
air leak | 12 |
alveolar damage | 12 |
transmission dynamics | 12 |
transplant patients | 12 |
laboratory investigations | 12 |
sedimentation rate | 12 |
us iv | 12 |
renal function | 12 |
wall motion | 12 |
lower extremity | 12 |
current covid | 12 |
supportive care | 12 |
citizen science | 12 |
cutaneous manifestations | 12 |
lithium toxicity | 12 |
literature review | 12 |
health revival | 12 |
iv iv | 12 |
york city | 12 |
deep vein | 12 |
rt alone | 12 |
early diagnosis | 12 |
early phase | 12 |
vl dl | 11 |
first reported | 11 |
year medical | 11 |
replacement therapy | 11 |
new cases | 11 |
clinical improvement | 11 |
gi symptoms | 11 |
six patients | 11 |
symptomatic patients | 11 |
also showed | 11 |
health professionals | 11 |
patient communication | 11 |
returned positive | 11 |
lung opacity | 11 |
signs symptoms | 11 |
refugee children | 11 |
authors concluded | 11 |
current literature | 11 |
breath sounds | 11 |
cardiac manifestations | 11 |
positive patient | 11 |
disease caused | 11 |
without respiratory | 11 |
dermatological lesions | 11 |
erythrocyte sedimentation | 11 |
status epilepticus | 11 |
stress disorder | 11 |
acute liver | 11 |
healthcare settings | 11 |
medical community | 11 |
clinical symptoms | 11 |
right lower | 11 |
fusobacterium nucleatum | 11 |
blood gas | 11 |
mortality risk | 11 |
study reported | 11 |
gy fraction | 11 |
heart injury | 11 |
six months | 11 |
halo sign | 11 |
ct angiography | 11 |
health workers | 11 |
elevated levels | 11 |
based module | 11 |
education level | 11 |
recent studies | 11 |
filtration efficacy | 11 |
management system | 11 |
previous studies | 11 |
five cmbs | 11 |
health coach | 11 |
expiratory pressure | 11 |
formative assessment | 11 |
cerebrovascular disease | 11 |
study protocol | 11 |
ct images | 11 |
systematic reviews | 11 |
small sample | 11 |
adult patients | 11 |
mildly symptomatic | 11 |
pcr results | 11 |
active cases | 11 |
bone marrow | 11 |
venous thrombosis | 11 |
distancing measures | 11 |
may present | 11 |
coronavirus family | 11 |
worldwide pandemic | 11 |
cardiac involvement | 11 |
global health | 11 |
south korea | 11 |
prothrombin time | 11 |
glucose levels | 11 |
clinical diagnosis | 11 |
virus disease | 11 |
pandemic date | 11 |
lactic acid | 11 |
psychological impact | 11 |
severe hypoxia | 11 |
platelet therapy | 11 |
radiological findings | 11 |
associated acute | 11 |
inspired oxygen | 11 |
san bernardino | 11 |
suspected cases | 11 |
clinical picture | 11 |
affected individuals | 11 |
within normal | 10 |
avaps mode | 10 |
bacterial meningitis | 10 |
less likely | 10 |
normal limits | 10 |
epidural abscess | 10 |
retrospective analysis | 10 |
immunosuppressive agents | 10 |
stroke risk | 10 |
like illness | 10 |
viral shedding | 10 |
respiratory therapy | 10 |
partial pressure | 10 |
trend towards | 10 |
program directors | 10 |
ventricular ejection | 10 |
commonly seen | 10 |
kidney transplant | 10 |
recent travel | 10 |
infected individuals | 10 |
leukocyte count | 10 |
two months | 10 |
medical knowledge | 10 |
dermatological manifestations | 10 |
asymptomatic sars | 10 |
dose anticoagulation | 10 |
hemodynamic instability | 10 |
infective endocarditis | 10 |
studies show | 10 |
evidence suggests | 10 |
beats min | 10 |
nasopharyngeal swabs | 10 |
online learning | 10 |
controlled trials | 10 |
paving pattern | 10 |
blood cells | 10 |
chest imaging | 10 |
label non | 10 |
back positive | 10 |
cuff leak | 10 |
low risk | 10 |
clinical data | 10 |
disease progression | 10 |
plasminogen activator | 10 |
total cases | 10 |
hypoxic respiratory | 10 |
metabolic acidosis | 10 |
much higher | 10 |
positive cases | 10 |
homemade masks | 10 |
physical distancing | 10 |
showed normal | 10 |
day course | 10 |
frequent hand | 10 |
academic year | 10 |
seven patients | 10 |
eight patients | 10 |
fulminant myocarditis | 10 |
traumatic stress | 10 |
medical literature | 10 |
google scholar | 10 |
geographic information | 10 |
exact mechanism | 10 |
situation reports | 10 |
bacterial infections | 10 |
host cells | 10 |
multiple studies | 10 |
hypoxemic respiratory | 10 |
ill covid | 10 |
disease risk | 10 |
patients present | 10 |
diffuse alveolar | 10 |
study aims | 10 |
consecutive days | 10 |
burn center | 10 |
time period | 10 |
pressure mmhg | 10 |
right lung | 10 |
may lead | 10 |
hemodialysis patients | 10 |
close monitoring | 10 |
leading cause | 10 |
new coronavirus | 10 |
respiratory viral | 10 |
organ transplant | 10 |
aspartate aminotransferase | 10 |
cytokine release | 10 |
conventional fractionation | 10 |
barr virus | 10 |
health system | 10 |
surgical resection | 10 |
patients received | 10 |
mean serum | 10 |
highly contagious | 10 |
precautionary measures | 10 |
previous history | 10 |
requiring intubation | 10 |
locally advanced | 10 |
wsu som | 10 |
previously healthy | 10 |
rebreather mask | 10 |
interstitial pneumonia | 10 |
functional exhaustion | 10 |
patient portals | 10 |
environmental health | 10 |
troponin elevation | 10 |
years ago | 10 |
cancer treatment | 10 |
patients diagnosed | 10 |
severe illness | 10 |
retrospective case | 10 |
symptom onset | 10 |
include fever | 10 |
lung surgery | 10 |
patient also | 10 |
serum iron | 10 |
stroke patients | 10 |
viral entry | 10 |
clinical presentations | 10 |
patient received | 10 |
testing positive | 10 |
commonly reported | 10 |
lung parenchyma | 10 |
natriuretic peptide | 10 |
symptom management | 10 |
positive end | 10 |
symptoms include | 9 |
acute coronary | 9 |
showed sinus | 9 |
nursing staff | 9 |
research output | 9 |
ct chest | 9 |
neutralizing antibodies | 9 |
china clinical | 9 |
descriptive statistics | 9 |
morbid obesity | 9 |
chest radiograph | 9 |
altered level | 9 |
psychiatric disorders | 9 |
every hours | 9 |
cord asc | 9 |
revealed bilateral | 9 |
acute hypoxic | 9 |
cardiac disease | 9 |
common cold | 9 |
national institute | 9 |
renal transplant | 9 |
important role | 9 |
clot formation | 9 |
point likert | 9 |
cardiovascular diseases | 9 |
ethics committee | 9 |
clinical findings | 9 |
without contrast | 9 |
ibm spss | 9 |
electronic medical | 9 |
new onset | 9 |
alanine aminotransferase | 9 |
without cardiac | 9 |
us reported | 9 |
mm hg | 9 |
differential diagnoses | 9 |
severe coronavirus | 9 |
elevated liver | 9 |
piperacillin tazobactam | 9 |
continuing medical | 9 |
significant past | 9 |
increasing number | 9 |
promising results | 9 |
present study | 9 |
severe patients | 9 |
confidence interval | 9 |
pressure ventilation | 9 |
urine antigen | 9 |
community hospital | 9 |
also present | 9 |
acute renal | 9 |
laboratory data | 9 |
limited data | 9 |
brain barrier | 9 |
glasgow coma | 9 |
tobacco use | 9 |
coma scale | 9 |
three weeks | 9 |
volunteering students | 9 |
deep venous | 9 |
following day | 9 |
retrospective review | 9 |
decision making | 9 |
sjs ten | 9 |
american college | 9 |
acceptance rate | 9 |
ebola virus | 9 |
flow reserve | 9 |
pressure room | 9 |
rna polymerase | 9 |
among hcp | 9 |
review date | 9 |
thoracic surgery | 9 |
legionnaires disease | 9 |
time rt | 9 |
higher prevalence | 9 |
reference range | 9 |
elevated troponin | 9 |
mechanically ventilated | 9 |
healthcare staff | 9 |
fractional flow | 9 |
mechanical ventilator | 9 |
disease process | 9 |
five fractions | 9 |
transplant recipient | 9 |
history presented | 9 |
high flow | 9 |
resistant staphylococcus | 9 |
remained stable | 9 |
via respiratory | 9 |
health risk | 9 |
productive cough | 9 |
time course | 9 |
intravenous antibiotics | 9 |
reporting items | 9 |
medical records | 9 |
frequently reported | 9 |
diagnostic criteria | 9 |
intracerebral hemorrhage | 9 |
cloth mask | 9 |
negative results | 9 |
electronic health | 9 |
made available | 9 |
mortality among | 9 |
pakistan reported | 9 |
rapid spread | 9 |
liver failure | 9 |
older adults | 9 |
host country | 9 |
health conditions | 9 |
blood urea | 9 |
sinus rhythm | 9 |
patients developed | 9 |
preferred reporting | 9 |
developed severe | 9 |
communion cup | 9 |
eight hours | 9 |
neurological involvement | 9 |
urea nitrogen | 9 |
information systems | 9 |
coronavirus pandemic | 9 |
airway pressure | 9 |
reported outcomes | 9 |
family members | 9 |
substance abuse | 9 |
health systems | 9 |
high clinical | 9 |
nasal swab | 9 |
remote learning | 9 |
renal replacement | 9 |
five years | 9 |
existing comorbidities | 9 |
dl iv | 8 |
east karachi | 8 |
oxygen requirements | 8 |
poor outcomes | 8 |
th percentile | 8 |
acute hepatitis | 8 |
respiratory viruses | 8 |
novel sars | 8 |
bilateral infiltrates | 8 |
back pain | 8 |
substance use | 8 |
significant association | 8 |
presenting symptoms | 8 |
present report | 8 |
spread worldwide | 8 |
cd cd | 8 |
cognitive impairment | 8 |
cognitive bias | 8 |
current pandemic | 8 |
severely ill | 8 |
highest number | 8 |
higher levels | 8 |
using ibm | 8 |
infection among | 8 |
immunodeficiency virus | 8 |
pandemic caused | 8 |
currently available | 8 |
direct patient | 8 |
analyzed using | 8 |
ct angiogram | 8 |
community parks | 8 |
day history | 8 |
clinical outcome | 8 |
urine analysis | 8 |
fluid accumulation | 8 |
socioeconomic status | 8 |
protective measures | 8 |
cardiac arrhythmias | 8 |
serum vitamin | 8 |
various clinical | 8 |
may help | 8 |
mg every | 8 |
patients will | 8 |
vl iv | 8 |
patients died | 8 |
potential therapeutic | 8 |
acute stroke | 8 |
pediatric patients | 8 |
severe form | 8 |
preventive measures | 8 |
high prevalence | 8 |
atypical presentation | 8 |
patient information | 8 |
rapidly spread | 8 |
oxidative stress | 8 |
infection prevention | 8 |
patient showed | 8 |
viral particles | 8 |
transcriptase polymerase | 8 |
getting infected | 8 |
see table | 8 |
students entering | 8 |
included studies | 8 |
peripheral blood | 8 |
adequate protection | 8 |
mean arterial | 8 |
likely due | 8 |
year three | 8 |
onset anosmia | 8 |
third day | 8 |
old patient | 8 |
university hospital | 8 |
ii pneumocytes | 8 |
like symptoms | 8 |
fast food | 8 |
either nifedipine | 8 |
pandemic continues | 8 |
ambulatory surgery | 8 |
clinical condition | 8 |
typical imaging | 8 |
elevation myocardial | 8 |
tests showed | 8 |
oxygen therapy | 8 |
agents may | 8 |
atypical symptoms | 8 |
negative test | 8 |
community spread | 8 |
diagnostic challenge | 8 |
acute heart | 8 |
eligible studies | 8 |
ace expression | 8 |
five cases | 8 |
urine cultures | 8 |
em residency | 8 |
direct contact | 8 |
renal disease | 8 |
treating patients | 8 |
transthoracic echocardiography | 8 |
individual medical | 8 |
grade fever | 8 |
clinical experience | 8 |
tract infection | 8 |
common presenting | 8 |
linear regression | 8 |
surgical repair | 8 |
urine culture | 8 |
anion gap | 8 |
preoperative rt | 8 |
early detection | 8 |
mild flu | 8 |
resolution ct | 8 |
next day | 8 |
associated pneumonia | 8 |
organ dysfunction | 8 |
legionella pneumophila | 8 |
weight loss | 8 |
children years | 8 |
comprehensive review | 8 |
patient denied | 8 |
online education | 8 |
iron levels | 8 |
definitive treatment | 8 |
peripheral distribution | 8 |
neurological features | 8 |
iv drug | 8 |
series study | 8 |
passive immunization | 8 |
three cases | 8 |
human transmission | 8 |
statistical package | 8 |
recent outbreak | 8 |
pericardial effusion | 8 |
serum creatinine | 8 |
advanced age | 8 |
hypovolemic hyponatremia | 8 |
immune status | 8 |
function tests | 8 |
cell entry | 8 |
thrombotic events | 8 |
spss statistics | 8 |
admitted patients | 8 |
aged years | 8 |
age range | 8 |
time polymerase | 8 |
patient underwent | 8 |
disseminated intravascular | 8 |
rheumatoid arthritis | 8 |
care units | 8 |
patients also | 8 |
common clinical | 8 |
health burdens | 8 |
infected person | 8 |
patients undergoing | 8 |
emergency surgery | 8 |
public places | 8 |
mm hr | 8 |
intravenous fluids | 8 |
blood tests | 8 |
body temperature | 8 |
available data | 8 |
mild covid | 8 |
physical exam | 8 |
requiring oxygen | 8 |
paramount importance | 8 |
hcq treated | 8 |
early stages | 8 |
time frame | 8 |
cerebrovascular accidents | 8 |
positive blood | 8 |
angiotensin system | 8 |
serum osmolality | 8 |
conservative management | 8 |
may result | 8 |
iv cannulation | 8 |
hiv patients | 8 |
immunocompromised state | 8 |
cerebral edema | 8 |
day one | 8 |
positive pressure | 8 |
median overall | 8 |
may prove | 8 |
residency program | 8 |
arterial thrombosis | 8 |
endothelial injury | 8 |
marion county | 8 |
deep inspiration | 8 |
many patients | 8 |
solid organ | 7 |
center retrospective | 7 |
close contacts | 7 |
common risk | 7 |
limited resources | 7 |
arterial pressure | 7 |
motion abnormalities | 7 |
may develop | 7 |
symptoms included | 7 |
atrial thrombus | 7 |
asymptomatic carriers | 7 |
cases worldwide | 7 |
sinus tachycardia | 7 |
may provide | 7 |
ray revealed | 7 |
supportive therapy | 7 |
within days | 7 |
blood vessels | 7 |
chief complaint | 7 |
iv fluids | 7 |
corona virus | 7 |
care provider | 7 |
three studies | 7 |
tissue plasminogen | 7 |
cell counts | 7 |
treatment group | 7 |
isolated sudden | 7 |
increased expression | 7 |
communication skills | 7 |
randomized trial | 7 |
vasopressor support | 7 |
simulation scenario | 7 |
bernardino county | 7 |
negative rt | 7 |
day two | 7 |
mental illness | 7 |
day four | 7 |
factors associated | 7 |
based modules | 7 |
antiviral activity | 7 |
care hospital | 7 |
mitral valve | 7 |
fluid replacement | 7 |
study included | 7 |
among doctors | 7 |
left side | 7 |
food restaurants | 7 |
right atrial | 7 |
treated patients | 7 |
even death | 7 |
sensitive staphylococcus | 7 |
rt dose | 7 |
familial cluster | 7 |
oral transmission | 7 |
relative bradycardia | 7 |
ongoing clinical | 7 |
patient outcomes | 7 |
public awareness | 7 |
correlation coefficient | 7 |
also seen | 7 |
male patient | 7 |
significant morbidity | 7 |
wide spectrum | 7 |
immunocompromised patients | 7 |
may occur | 7 |
pneumonia caused | 7 |
transthoracic echocardiogram | 7 |
direct viral | 7 |
failure secondary | 7 |
clinical efficacy | 7 |
presentation tool | 7 |
primary hyperparathyroidism | 7 |
study participants | 7 |
healthy individuals | 7 |
deaths due | 7 |
intravascular coagulation | 7 |
last three | 7 |
pulmonary edema | 7 |
per capita | 7 |
disease pandemic | 7 |
passed away | 7 |
contrast revealed | 7 |
vascular risk | 7 |
spontaneous air | 7 |
discharged patients | 7 |
ground glass | 7 |
prospective study | 7 |
pui protocol | 7 |
coronavirus covid | 7 |
possible mechanisms | 7 |
acute hemorrhagic | 7 |
mitral regurgitation | 7 |
age groups | 7 |
effective treatment | 7 |
also developed | 7 |
bronchoalveolar lavage | 7 |
ischemic strokes | 7 |
mainly due | 7 |
coronary angiography | 7 |
contaminated surfaces | 7 |
health concerns | 7 |
showed significant | 7 |
rapidly evolving | 7 |
days ago | 7 |
pancreatic beta | 7 |
vaccine development | 7 |
teaching hospital | 7 |
home isolation | 7 |
stereotactic body | 7 |
viral genome | 7 |
protective gear | 7 |
faculty members | 7 |
march th | 7 |
may need | 7 |
interstitial pneumonias | 7 |
higher rates | 7 |
barre syndrome | 7 |
insurance status | 7 |
generalized tonic | 7 |
spread rapidly | 7 |
clinical profile | 7 |
chronic health | 7 |
specific health | 7 |
cancer mortality | 7 |
novel virus | 7 |
spontaneous pneumothorax | 7 |
significant differences | 7 |
pao fio | 7 |
oxygen reservoir | 7 |
first day | 7 |
rural areas | 7 |
tnt levels | 7 |
human immunodeficiency | 7 |
may experience | 7 |
adrenal insufficiency | 7 |
ccb treatment | 7 |
communicable diseases | 7 |
requiring mechanical | 7 |
aortic valve | 7 |
intravenous immunoglobulin | 7 |
injury due | 7 |
cell membrane | 7 |
receptor binding | 7 |
dermatological symptoms | 7 |
initial laboratory | 7 |
co wards | 7 |
health sciences | 7 |
small vessels | 7 |
several days | 7 |
structural proteins | 7 |
insulin resistance | 7 |
reproductive number | 7 |
cardiac catheterization | 7 |
inflammatory cells | 7 |
presenting feature | 7 |
qtc interval | 7 |
positive results | 7 |
young patients | 7 |
resource management | 7 |
atypical presentations | 7 |
therapeutic option | 7 |
skeletal muscle | 7 |
ct showed | 7 |
confirmed case | 7 |
adverse outcomes | 7 |
clinically proven | 7 |
different countries | 7 |
care professionals | 7 |
patient management | 7 |
technical report | 7 |
disease temperature | 7 |
review article | 7 |
another case | 7 |
showed diffuse | 7 |
ventilatory support | 7 |
hospital transmission | 7 |
subconjunctival hemorrhages | 7 |
one year | 7 |
drug screen | 7 |
international medical | 7 |
symptom severity | 7 |
allostatic load | 7 |
adversely affected | 7 |
outpatient setting | 7 |
positive airway | 7 |
asymptomatic individuals | 7 |
autoimmune diseases | 7 |
cda grade | 7 |
presentation rating | 7 |
law enforcement | 7 |
severe infection | 7 |
ncov pneumonia | 7 |
population density | 7 |
acute encephalopathy | 7 |
urine drug | 7 |
pleural effusions | 7 |
study demonstrated | 7 |
tertiary medical | 7 |
hydrogen peroxide | 7 |
cell carcinoma | 7 |
oxygen flow | 7 |
available literature | 7 |
hemodynamically stable | 7 |
patient required | 7 |
significantly elevated | 7 |
severe sepsis | 7 |
proposed mechanisms | 7 |
survey instrument | 7 |
analysis showed | 7 |
negative correlation | 7 |
two studies | 7 |
angiotensin converting | 7 |
treatment option | 7 |
studies will | 7 |
symptoms like | 7 |
painful stimuli | 7 |
care plans | 7 |
systemic disease | 7 |
larger sample | 7 |
bilateral patchy | 7 |
four cases | 7 |
crisis resource | 7 |
published case | 7 |
high rate | 7 |
mg po | 7 |
disease assessment | 7 |
medical center | 7 |
initially presented | 7 |
reversed halo | 7 |
pressure support | 7 |
clinical manifestation | 7 |
internal medicine | 7 |
transient ischemic | 7 |
severe symptoms | 7 |
infarction ventricular | 7 |
median time | 7 |
oral cavity | 7 |
soft tissue | 7 |
common cause | 7 |
use disorders | 7 |
airway protection | 7 |
may increase | 7 |
diagnostic tool | 7 |
cardiovascular system | 7 |
people worldwide | 7 |
rna virus | 7 |
worsening respiratory | 7 |
hemolytic anemia | 6 |
two years | 6 |
acute abnormalities | 6 |
negative impact | 6 |
among health | 6 |
medical equipment | 6 |
low serum | 6 |
orthopaedic surgeries | 6 |
significant improvement | 6 |
assisted treatment | 6 |
per million | 6 |
acute cerebrovascular | 6 |
ccta studies | 6 |
virus particles | 6 |
deaths worldwide | 6 |
social isolation | 6 |
among adolescents | 6 |
pulmonary arterial | 6 |
partial thromboplastin | 6 |
minimally invasive | 6 |
physical activity | 6 |
cytokine storms | 6 |
critical cases | 6 |
insulin drip | 6 |
secondary infection | 6 |
failure requiring | 6 |
patient without | 6 |
severe complications | 6 |
major criteria | 6 |
proven protease | 6 |
head showed | 6 |
health record | 6 |
older age | 6 |
qt prolongation | 6 |
valproic acid | 6 |
wound care | 6 |
consider cytokine | 6 |
mild cases | 6 |
rare cause | 6 |
single center | 6 |
wearing ppe | 6 |
risk portfolio | 6 |
release syndrome | 6 |
developing countries | 6 |
lung infections | 6 |
vast majority | 6 |
class obesity | 6 |
therapeutic approach | 6 |
developed acute | 6 |
mg day | 6 |
sick contacts | 6 |
recently published | 6 |
positive test | 6 |
bilateral pulmonary | 6 |
important lessons | 6 |
available resources | 6 |
ct features | 6 |
immunosuppressed state | 6 |
jesus christ | 6 |
syncytial virus | 6 |
outpatient clinic | 6 |
reported fever | 6 |
treatment guidelines | 6 |
several countries | 6 |
ill icu | 6 |
including covid | 6 |
positive rt | 6 |
storm syndromes | 6 |
significant role | 6 |
disease relapse | 6 |
less common | 6 |
positive attitude | 6 |
cases performed | 6 |
face shield | 6 |
suit gown | 6 |
viral myocarditis | 6 |
coronavirus outbreak | 6 |
inspiratory hold | 6 |
social support | 6 |
senior medical | 6 |
steering committee | 6 |
calcium channel | 6 |
hemorrhagic necrotizing | 6 |
necrotizing encephalopathy | 6 |
task force | 6 |
also observed | 6 |
sleep apnea | 6 |
racial disparity | 6 |
compartment syndrome | 6 |
gas exchange | 6 |
least two | 6 |
synchronous telemedicine | 6 |
mrsa meningitis | 6 |
potential treatment | 6 |
cxr showed | 6 |
coronary syndrome | 6 |
patient became | 6 |
also started | 6 |
cerebral hemorrhage | 6 |
rational use | 6 |
patient continued | 6 |
ray findings | 6 |
second day | 6 |
showed signs | 6 |
ambient air | 6 |
health improvement | 6 |
mortality due | 6 |
appropriate use | 6 |
studies included | 6 |
findings showed | 6 |
system involvement | 6 |
emergency departments | 6 |
rate min | 6 |
prior use | 6 |
oral presentations | 6 |
care physician | 6 |
online survey | 6 |
related complications | 6 |
medical personnel | 6 |
severe sars | 6 |
compartment epidemiology | 6 |
times higher | 6 |
systemic inflammation | 6 |
four hours | 6 |
make sure | 6 |
risk population | 6 |
limited access | 6 |
patients requiring | 6 |
virus transmission | 6 |
high dose | 6 |
possible vertical | 6 |
chronic condition | 6 |
airway management | 6 |
spread across | 6 |
retrospective studies | 6 |
despite aggressive | 6 |
fatal outcomes | 6 |
days vs | 6 |
disease patients | 6 |
hca healthcare | 6 |
examination showed | 6 |
cardiac complications | 6 |
nine days | 6 |
household income | 6 |
remains unknown | 6 |
video laryngoscopy | 6 |
death toll | 6 |
patient data | 6 |
anterior uveitis | 6 |
healthcare facilities | 6 |
medical centers | 6 |
autopsy findings | 6 |
model results | 6 |
mean duration | 6 |
metabolic panel | 6 |
entry depends | 6 |
chronic liver | 6 |
electrocardiogram showed | 6 |
recovered cases | 6 |
social sciences | 6 |
typical symptoms | 6 |
postinfarction vsr | 6 |
work without | 6 |
online conferences | 6 |
streptococcus pneumoniae | 6 |
may potentially | 6 |
affected patients | 6 |
every eight | 6 |
letter grade | 6 |
minority communities | 6 |
healthy patients | 6 |
cases per | 6 |
presenting symptom | 6 |
corrected qt | 6 |
acute limb | 6 |
virus origins | 6 |
dimer level | 6 |
multidisciplinary team | 6 |
sectional survey | 6 |
ami patients | 6 |
positive correlation | 6 |
demographic data | 6 |
cells mm | 6 |
diagnostic test | 6 |
normal sinus | 6 |
net hospital | 6 |
initial symptoms | 6 |
study period | 6 |
elevated tnt | 6 |
four months | 6 |
red blood | 6 |
positive pregnant | 6 |
condition improved | 6 |
racial disparities | 6 |
affected countries | 6 |
early transmission | 6 |
nine patients | 6 |
medications included | 6 |
sellar mass | 6 |
markedly elevated | 6 |
wide variety | 6 |
patients covid | 6 |
iv antibiotics | 6 |
current evidence | 6 |
media platforms | 6 |
novel severe | 6 |
identify patients | 6 |
may reflect | 6 |
oral mucosa | 6 |
asylum seekers | 6 |
table shows | 6 |
glass pattern | 6 |
tract infections | 6 |
proper use | 6 |
organ transplantation | 6 |
recent quarter | 6 |
status continued | 6 |
esrd patients | 6 |
regression analysis | 6 |
reported symptoms | 6 |
randomized control | 6 |
term use | 6 |
center study | 6 |
vaping knowledge | 6 |
beta cells | 6 |
search strategy | 6 |
positive covid | 6 |
remains unclear | 6 |
infection associated | 6 |
psychological distress | 6 |
findings included | 6 |
stimulating hormone | 6 |
blood sugar | 6 |
normal value | 6 |
toward online | 6 |
died within | 6 |
imaging findings | 6 |
study performed | 6 |
tracheal aspirate | 6 |
lung edema | 6 |
acute bronchospasm | 6 |
adult adhd | 6 |
covid patients | 6 |
prior studies | 6 |
intravenous cannulation | 6 |
care setting | 6 |
cardiac output | 6 |
national health | 6 |
respiratory syncytial | 6 |
old hispanic | 6 |
readily available | 6 |
infection due | 6 |
ventricular dysfunction | 6 |
disease burden | 6 |
legionella infection | 6 |
clinical deterioration | 6 |
healthcare professional | 6 |
immune responses | 6 |
limb ischemia | 6 |
preoperative radiation | 6 |
developed respiratory | 6 |
month period | 6 |
surgery decreased | 6 |
computer use | 6 |
impaired consciousness | 6 |
supportive treatment | 6 |
among others | 6 |
research studies | 6 |
medical treatment | 6 |
chest tightness | 6 |
daytime sleepiness | 6 |
median number | 6 |
rating tool | 6 |
study reports | 6 |
among healthcare | 6 |
nursing home | 6 |
upper lobe | 6 |
among hcws | 6 |
selected patients | 6 |
obstructive sleep | 6 |
slt products | 6 |
study concluded | 6 |
published studies | 6 |
disease onset | 6 |
respiratory diseases | 6 |
consensus statement | 6 |
prepare students | 6 |
patients underwent | 6 |
laboratory results | 6 |
study involving | 6 |
breaths minute | 6 |
patient date | 6 |
bipolar disorder | 6 |
team members | 6 |
cardiovascular manifestations | 6 |
ct scans | 6 |
left middle | 6 |
chest computed | 6 |
ten days | 6 |
broad spectrum | 6 |
detention centers | 6 |
pneumonia cases | 6 |
large number | 6 |
ventilated patients | 6 |
expired group | 6 |
across multiple | 6 |
surgical candidates | 6 |
conservative treatment | 6 |
health authorities | 6 |
potential covid | 6 |
study found | 6 |
multicenter study | 6 |
muscle injury | 6 |
improved mortality | 6 |
operating room | 6 |
radiographic findings | 6 |
spectrum antiviral | 6 |
influenza virus | 6 |
arab world | 6 |
clinical status | 6 |
patients recovered | 6 |
categorical variables | 6 |
performance status | 6 |
residents must | 6 |
cribriform plate | 6 |
stage renal | 6 |
many hospitals | 6 |
cases reported | 6 |
low levels | 6 |
eight weeks | 6 |
public gatherings | 6 |
clinical education | 6 |
operative risks | 6 |
pandemic covid | 6 |
many countries | 6 |
significant risk | 6 |
healthcare needs | 6 |
data available | 6 |
left lower | 6 |
wuhan city | 6 |
thromboplastin time | 6 |
also demonstrated | 5 |
magnesium sulfate | 5 |
medical decision | 5 |
acute disseminated | 5 |
upper reference | 5 |
ventricular tachycardia | 5 |
pcr analysis | 5 |
virus detection | 5 |
fungal osteomyelitis | 5 |
acute bilateral | 5 |
health issues | 5 |
possible cause | 5 |
emergency use | 5 |
dose steroids | 5 |
include acute | 5 |
cryptococcus neoformans | 5 |
elevated inflammatory | 5 |
quarantine measures | 5 |
surgical intervention | 5 |
prisma statement | 5 |
require mechanical | 5 |
complications related | 5 |
reference limit | 5 |
ct head | 5 |
otherwise healthy | 5 |
current global | 5 |
scientific community | 5 |
joint pain | 5 |
timely diagnosis | 5 |
inflammatory storm | 5 |
health disorders | 5 |
lower limbs | 5 |
clinical judgment | 5 |
term awake | 5 |
elevated cardiac | 5 |
local community | 5 |
old caucasian | 5 |
sbcyor program | 5 |
treatment coronavirus | 5 |
postmortem findings | 5 |
elective cases | 5 |
psychological first | 5 |
studies related | 5 |
hyaline membrane | 5 |
hospital care | 5 |
associated coagulopathy | 5 |
worse outcome | 5 |
decreased risk | 5 |
gi societies | 5 |
comorbid conditions | 5 |
human body | 5 |
management strategy | 5 |
printed ventilator | 5 |
also help | 5 |
using avaps | 5 |
research activity | 5 |
virus may | 5 |
pneumonia associated | 5 |
first identified | 5 |
also associated | 5 |
laboratory abnormalities | 5 |
recent literature | 5 |
exact test | 5 |
unknown etiology | 5 |
data regarding | 5 |
cd cells | 5 |
among covid | 5 |
learning management | 5 |
medical condition | 5 |
infect dis | 5 |
previous study | 5 |
viral encephalitis | 5 |
recent years | 5 |
test returned | 5 |
gross domestic | 5 |
odds ratio | 5 |
patients positive | 5 |
involving patients | 5 |
ethical approval | 5 |
aortic root | 5 |
geospatial analysis | 5 |
like picture | 5 |
ischemic attack | 5 |
abnormal laboratory | 5 |
week periods | 5 |
ischemic event | 5 |
economic times | 5 |
chest tube | 5 |
health complaints | 5 |
cases may | 5 |
million cases | 5 |
johns hopkins | 5 |
pituitary hormones | 5 |
see appendix | 5 |
staff shortages | 5 |
left upper | 5 |
patient characteristics | 5 |
onset seizures | 5 |
weight heparin | 5 |
discharge criteria | 5 |
patient stated | 5 |
academic hospital | 5 |
subcutaneous emphysema | 5 |
compassionate use | 5 |
also used | 5 |
bioprosthetic aortic | 5 |
following days | 5 |
encephalitis associated | 5 |
temporal region | 5 |
underlying medical | 5 |
long incubation | 5 |
hold technique | 5 |
square test | 5 |
head ct | 5 |
intracranial hemorrhage | 5 |
opioid response | 5 |
fatal outcome | 5 |
medication use | 5 |
em program | 5 |
transplant patient | 5 |
admission showed | 5 |
right shunting | 5 |
safety profile | 5 |
disease acute | 5 |
significant amount | 5 |
bradycardic episodes | 5 |
internship preparation | 5 |
img advising | 5 |
liver diseases | 5 |
qtc prolongation | 5 |
group vs | 5 |
ct technologists | 5 |
without myocardial | 5 |
studies showed | 5 |
patchy infiltrates | 5 |
least five | 5 |
rare case | 5 |
hypertension presented | 5 |
dihydropyridine calcium | 5 |
coronavirus sars | 5 |
two separate | 5 |
positive sars | 5 |
board issued | 5 |
enzyme receptor | 5 |
highly infectious | 5 |
hypercoagulable states | 5 |
analysis revealed | 5 |
lower risk | 5 |
medical record | 5 |
test result | 5 |
helps us | 5 |
oxygen support | 5 |
international community | 5 |
will allow | 5 |
students may | 5 |
relatively high | 5 |
virus infection | 5 |
pcr tests | 5 |
family history | 5 |
lymph nodes | 5 |
type natriuretic | 5 |
decreased appetite | 5 |
surgical debridement | 5 |
subarachnoid hemorrhage | 5 |
disseminated encephalomyelitis | 5 |
worsening shortness | 5 |
postinfarction ventricular | 5 |
fungal infections | 5 |
effective communication | 5 |
data analysis | 5 |
potential risk | 5 |
studies may | 5 |
beats minute | 5 |
china covid | 5 |
get infected | 5 |
survival group | 5 |
three hours | 5 |
early respiratory | 5 |
lung infiltrates | 5 |
person transmission | 5 |
common communion | 5 |
dendritic cells | 5 |
leak test | 5 |
body ache | 5 |
nasal cavity | 5 |
advising team | 5 |
coronavirus indicating | 5 |
radiologic findings | 5 |
sexually transmitted | 5 |
growth factor | 5 |
primary endpoint | 5 |
substantially higher | 5 |
higher compared | 5 |
stage disease | 5 |
cardiac markers | 5 |
established guidelines | 5 |
novel syndrome | 5 |
amniotic fluid | 5 |
deep learning | 5 |
febrile illness | 5 |
fleischner society | 5 |
less severe | 5 |
since december | 5 |
bilateral subconjunctival | 5 |
pretest probability | 5 |
direct damage | 5 |
doctors working | 5 |
four major | 5 |
parapsilosis osteomyelitis | 5 |
prediction layer | 5 |
reduce mortality | 5 |
patients suspected | 5 |
thromboembolic events | 5 |
early stage | 5 |
mechanical complication | 5 |
develop acute | 5 |
alone may | 5 |
weighted images | 5 |
sequential organ | 5 |
target population | 5 |
also improved | 5 |
mg orally | 5 |
medicine floor | 5 |
per fraction | 5 |
report date | 5 |
home care | 5 |
recovered patients | 5 |
patients experience | 5 |
liters nasal | 5 |
ocular manifestations | 5 |
spread throughout | 5 |
probnp levels | 5 |
first four | 5 |
based hand | 5 |
ongoing pandemic | 5 |
biochemical markers | 5 |
clonic seizures | 5 |
comprehensive assessment | 5 |
laboratory studies | 5 |
hrp doctor | 5 |
multifocal pneumonia | 5 |
interventional radiology | 5 |
task prediction | 5 |
adhd group | 5 |
several limitations | 5 |
management plan | 5 |
failure assessment | 5 |
unprecedented situation | 5 |
among adults | 5 |
person cohort | 5 |
vape use | 5 |
significant medical | 5 |
awareness among | 5 |
coronavirus nl | 5 |
fluid restriction | 5 |
data obtained | 5 |
hand sanitizer | 5 |
creatinine levels | 5 |
international committee | 5 |
median times | 5 |
diagnosed based | 5 |
health organisation | 5 |
artery pressure | 5 |
pandemic coronavirus | 5 |
sec vs | 5 |
status post | 5 |
icu admission | 5 |
high number | 5 |
clinically suspected | 5 |
increased prevalence | 5 |
influenza pandemic | 5 |
bilateral lower | 5 |
induced thrombocytopenia | 5 |
ventricular strain | 5 |
diastolic dysfunction | 5 |
alanine transaminase | 5 |
cigarette use | 5 |
laryngeal edema | 5 |
pilot study | 5 |
neurological manifestation | 5 |
current situation | 5 |
handed reference | 5 |
induced myocardial | 5 |
elevated serum | 5 |
chest radiography | 5 |
right side | 5 |
chronic lung | 5 |
online sessions | 5 |
successfully treated | 5 |
hyposmia anosmia | 5 |
neurological signs | 5 |
air bronchogram | 5 |
bronchospasm associated | 5 |
diagnostic studies | 5 |
rapidly spreading | 5 |
european society | 5 |
viral respiratory | 5 |
prospective randomized | 5 |
correct diagnosis | 5 |
research questions | 5 |
serum sodium | 5 |
sample sizes | 5 |
us dl | 5 |
inflammatory drugs | 5 |
came negative | 5 |
individual patient | 5 |
favorable outcome | 5 |
asynchronous telemedicine | 5 |
learning curriculum | 5 |
herd immunity | 5 |
viral dissemination | 5 |
independent risk | 5 |
clerkship directors | 5 |
test came | 5 |
one case | 5 |
type pneumocytes | 5 |
associated risk | 5 |
recent history | 5 |
modifiable risk | 5 |
remained afebrile | 5 |
results indicate | 5 |
report describes | 5 |
moderate disease | 5 |
questions regarding | 5 |
channel blockers | 5 |
fusobacterium species | 5 |
bradycardia resolution | 5 |
via nasal | 5 |
larger scale | 5 |
approximately one | 5 |
heart function | 5 |
blood oxygen | 5 |
widely reported | 5 |
first aid | 5 |
osleonsis bacteremia | 5 |
elevated white | 5 |
may affect | 5 |
expert opinion | 5 |
study group | 5 |
disease date | 5 |
multiorgan dysfunction | 5 |
successful treatment | 5 |
pulmonary symptoms | 5 |
loved ones | 5 |
review aims | 5 |
data showed | 5 |
pulmonary angiography | 5 |
high incidence | 5 |
laboratory values | 5 |
studies also | 5 |
requiring hospitalization | 5 |
close proximity | 5 |
wellness reminders | 5 |
based biomarkers | 5 |
death rate | 5 |
blood samples | 5 |
stress cardiomyopathy | 5 |
fibrinoid necrosis | 5 |
nrmp data | 5 |
control study | 5 |
reference frame | 5 |
health evaluation | 5 |
hospital due | 5 |
taking lithium | 5 |
syndrome associated | 5 |
reported data | 5 |
hellp syndrome | 5 |
showed mild | 5 |
infect humans | 5 |
systematic search | 5 |
severe group | 5 |
advising recommendations | 5 |
study also | 5 |
general anesthesia | 5 |
cotton cloth | 5 |
index case | 5 |
per year | 5 |
th day | 5 |
healthy male | 5 |
tidal volume | 5 |
transmitted via | 5 |
emerging novel | 5 |
crp levels | 5 |
receiving wellness | 5 |
management strategies | 5 |
still controversial | 5 |
lung tissue | 5 |
high rates | 5 |
treatment may | 5 |
iv dl | 5 |
mild respiratory | 5 |
presentation centered | 5 |
us vl | 5 |
pulmonary vascular | 5 |
systemic therapy | 5 |
iron deficiency | 5 |
good health | 5 |
commonly involved | 5 |
saliva droplets | 5 |
medical services | 5 |
developed worsening | 5 |
bilateral lung | 5 |
control trials | 5 |
useful tool | 5 |
radiographic assessment | 5 |
health data | 5 |
mouth contact | 5 |
interstitial fibrosis | 5 |
hypocretin levels | 5 |
right temporal | 5 |
successful extubation | 5 |
cardiac biomarkers | 5 |
volume status | 5 |
california hospitals | 5 |
surgical departments | 5 |
best practices | 5 |
coronavirus strains | 5 |
gaseous exchange | 5 |
patients affected | 5 |
showed right | 5 |
epidemiological study | 5 |
nephrotic syndrome | 5 |
rate beats | 5 |
special attention | 5 |
airborne precautions | 5 |
study evaluated | 5 |
clinical therapies | 5 |
emergency medical | 5 |
several weeks | 5 |
diagnostic tests | 5 |
will likely | 5 |
ct pulmonary | 5 |
inward protection | 5 |
endotracheal tube | 5 |
directly involved | 5 |
vascular endothelium | 5 |
fold increase | 5 |
american academy | 5 |
use among | 5 |
chemotherapy may | 5 |
hospital beds | 5 |
infected cases | 5 |
case basis | 5 |
masks compared | 5 |
neoplastic causes | 5 |
massive dvt | 5 |
treatment regimen | 5 |
critical covid | 5 |
symptoms may | 5 |
activated partial | 5 |
severe hypoxemia | 5 |
clinical case | 5 |
cell activation | 5 |
retrospective observational | 5 |
environmental factors | 5 |
pandemic situation | 5 |
large sample | 5 |
serum zinc | 5 |
may play | 5 |
students will | 5 |
blood flow | 5 |
emotional distress | 5 |
cardiovascular mortality | 5 |
cardiovascular radiologist | 5 |
ethnic disparities | 5 |
systemic inflammatory | 5 |
one dose | 5 |
lithium level | 5 |
sustentacular cells | 5 |
antiviral drugs | 5 |
two groups | 5 |
zinc levels | 5 |
attention deficit | 5 |
safe portal | 5 |
young age | 5 |
male patients | 5 |
neurological deficits | 5 |
among children | 5 |
improve patient | 5 |
factors include | 5 |
gradually decreased | 5 |
febrile seizures | 5 |
vascular permeability | 5 |
right shunt | 5 |
residency programs | 5 |
influenza viruses | 5 |
case investigation | 5 |
brooklyn hospital | 5 |
mixed pattern | 5 |
infection rate | 5 |
status deteriorated | 5 |
care beds | 5 |
brain natriuretic | 5 |
limited number | 5 |
hospital center | 5 |
genomic characterisation | 5 |
moderate covid | 5 |
lung diseases | 5 |
diagnostic tools | 5 |
monoclonal antibody | 5 |
storm syndrome | 5 |
domestic product | 5 |
testing kits | 5 |
vessel occlusion | 5 |
clinical use | 5 |
coronary intervention | 5 |
acute intracranial | 5 |
common chest | 5 |
chronic medical | 5 |
secondary bacterial | 5 |
right ventricle | 5 |
ml kg | 5 |
factor viii | 5 |
air delivery | 5 |
cystic changes | 5 |
risk based | 5 |
youth opioid | 5 |
improved outcomes | 5 |
will also | 5 |
independent sample | 5 |
also highlighted | 5 |
blood chemistry | 5 |
developed bradycardia | 5 |
predisposes patients | 5 |
two sets | 5 |
prostate cancer | 5 |
pediatric population | 5 |
young patient | 5 |
fasting glucose | 5 |
years vs | 5 |
hip arthroplasty | 5 |
disease management | 5 |
mental disorders | 5 |
develop symptoms | 5 |
hours prior | 5 |
longitudinal studies | 5 |
may actually | 5 |
care plan | 5 |
cda risk | 5 |
severe metabolic | 5 |
wave inversion | 5 |
literature search | 5 |
coronavirus oc | 5 |
case illustrates | 5 |
mental illnesses | 5 |
normal saline | 5 |
glass appearance | 5 |
root abscess | 5 |
numerous studies | 5 |
negatively correlated | 5 |
clinical settings | 5 |
kidney insufficiency | 5 |
creatine kinase | 5 |
vulnerable populations | 5 |
qualitative study | 5 |
chest showed | 5 |
results show | 5 |
higher rate | 5 |
dermatological clinical | 5 |
wuhan clinical | 5 |
health coaching | 5 |
healthcare resources | 5 |
intravenous fluid | 5 |
liters per | 5 |
pure ggo | 5 |
smooth muscle | 5 |
institutional isolation | 5 |
data suggest | 5 |
body radiation | 5 |
within two | 5 |
calcium level | 5 |
ocular complications | 5 |
lower extremities | 5 |
po daily | 5 |
may explain | 5 |
phase i | 5 |
gy per | 5 |
evidence regarding | 4 |
legionella urine | 4 |
related encephalitis | 4 |
antithrombin iii | 4 |
common among | 4 |
weeks prior | 4 |
sofa score | 4 |
implantable loop | 4 |
unaccompanied refugee | 4 |
american patients | 4 |
disease clinical | 4 |
become negative | 4 |
mssa bacteremia | 4 |
respiratory protective | 4 |
developed nations | 4 |
antibiotic treatment | 4 |
first patient | 4 |
viral pneumonias | 4 |
urgent ophthalmic | 4 |
systemic steroids | 4 |
patient visits | 4 |
power analysis | 4 |
modulation therapy | 4 |
clinical predictors | 4 |
target cells | 4 |
improve health | 4 |
activity tracking | 4 |
also called | 4 |
patients previously | 4 |
magnetic field | 4 |
vascular endothelial | 4 |
medical sciences | 4 |
successfully extubated | 4 |
loading dose | 4 |
artery bypass | 4 |
patient adherence | 4 |
healthy people | 4 |
hospitalization rates | 4 |
independently associated | 4 |
respiratory involvement | 4 |
local transmission | 4 |
superfund sites | 4 |
lymph node | 4 |
median scores | 4 |
positioning combined | 4 |
care settings | 4 |
patients using | 4 |
higher incidence | 4 |
data collected | 4 |
surgical closure | 4 |
required intubation | 4 |
mild troponin | 4 |
severe dyspnea | 4 |
normal heart | 4 |
surgical intensive | 4 |
organizing pneumonia | 4 |
following covid | 4 |
select patients | 4 |
st depression | 4 |
publicly reported | 4 |
regression model | 4 |
nearly every | 4 |
colon cancer | 4 |
hcq treatment | 4 |
pathological changes | 4 |
among sars | 4 |
prophylactic dose | 4 |
ii pneumocyte | 4 |
white population | 4 |
acute hypoxemic | 4 |
ekg showed | 4 |
disease include | 4 |
western region | 4 |
health coaches | 4 |
remained asymptomatic | 4 |
per person | 4 |
rapid progression | 4 |
may indicate | 4 |
core competencies | 4 |
takes place | 4 |
innate immune | 4 |
natural killer | 4 |
developed post | 4 |
may precede | 4 |
crp level | 4 |
social stigma | 4 |
viral pathogens | 4 |
like rash | 4 |
rejection rate | 4 |
workers regarding | 4 |
despite antibiotic | 4 |
first report | 4 |
procedures performed | 4 |
hemoglobin levels | 4 |
hemostatic mechanisms | 4 |
common findings | 4 |
laboratory workup | 4 |
effective measures | 4 |
underlying vessels | 4 |
respiratory secretions | 4 |
growing number | 4 |
one rct | 4 |
enrolled patients | 4 |
right cerebellar | 4 |
significantly older | 4 |
scientific brief | 4 |
extremely confident | 4 |
epidemiology model | 4 |
surgical management | 4 |
opportunistic infections | 4 |
community outreach | 4 |
first time | 4 |
frequent neurological | 4 |
mask use | 4 |
therapy consisting | 4 |
myocardial inflammation | 4 |
gag reflexes | 4 |
recent evidence | 4 |
novel covid | 4 |
phase iii | 4 |
attending faculty | 4 |
vascular dementia | 4 |
trusted sources | 4 |
cultures showed | 4 |
rate among | 4 |
airborne transmission | 4 |
high serum | 4 |
million population | 4 |
several clinical | 4 |
commonly associated | 4 |
university school | 4 |
runny nose | 4 |
percentile upper | 4 |
pid controller | 4 |
afebrile seizure | 4 |
four weeks | 4 |
mg tablet | 4 |
progressively worsening | 4 |
contact dermatitis | 4 |
medical doctors | 4 |
pacemaker cells | 4 |
data will | 4 |
less frequent | 4 |
prone ventilation | 4 |
neonates born | 4 |
health risks | 4 |
one month | 4 |
tracheal intubation | 4 |
daily routines | 4 |
infectious populations | 4 |
heparin products | 4 |
health measures | 4 |
threatening injuries | 4 |
per month | 4 |
gustatory dysfunctions | 4 |
surgical procedures | 4 |
persistent bacteremia | 4 |
multimodal therapy | 4 |
total dose | 4 |
hospital protocol | 4 |
intubated patients | 4 |
neurological presentations | 4 |
cause respiratory | 4 |
induced lung | 4 |
next three | 4 |
five months | 4 |
azithromycin mg | 4 |
consecrated bread | 4 |
phase proteins | 4 |
calculated using | 4 |
cardiovascular considerations | 4 |
transcription polymerase | 4 |
popliteal artery | 4 |
also received | 4 |
transmembrane protease | 4 |
cancer patient | 4 |
peer review | 4 |
muscle aches | 4 |
maculopapular rash | 4 |
nccn recommends | 4 |
towards increased | 4 |
also significantly | 4 |
outpatient clinics | 4 |
viral syndrome | 4 |
carbon dioxide | 4 |